NOT KNOWN FACTUAL STATEMENTS ABOUT SIKIş

Addyi was initially approved from the FDA in August 2015 to treat hypoactive sexual need dysfunction (HSDD) in premenopausal Women of all ages. Which is just yet another way of claiming it boosts sexual intercourse travel (also known as libido) in women that have not attained menopause. It had been the 1st these types of drug authorised for this us